| Literature DB >> 35721715 |
Pengyi Yu1,2, Xinxin Wu1,2, Jingjing Li1,2, Ning Mao3,4, Haicheng Zhang3, Guibin Zheng5, Xiao Han1,2, Luchao Dong1,2,6, Kaili Che4, Qinglin Wang4, Guan Li4, Yakui Mou1,2, Xicheng Song1,2.
Abstract
Objectives: To develop and validate a Computed Tomography (CT) based radiomics nomogram for preoperative predicting of extrathyroidal extension (ETE) in papillary thyroid cancer (PTC) patients.Entities:
Keywords: contrast-enhanced CT; extrathyroidal extension (ETE); nomogram; papillary thyroid cancer; radiomics
Mesh:
Year: 2022 PMID: 35721715 PMCID: PMC9198261 DOI: 10.3389/fendo.2022.874396
Source DB: PubMed Journal: Front Endocrinol (Lausanne) ISSN: 1664-2392 Impact factor: 6.055
Figure 1Flow chart of patients’ enrolment in (A) training, internal test set and (B) external test set. (C) Flow chart of study work. (D, E) Examples of regions of interest (ROIs) segmentation on contrast-enhanced computed tomography (CE-CT) images.
Characteristic of enrolled patients in three sets.
| Training Set (n = 107) | Internal Test Set (n = 46) | External Test Set (n = 46) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| ETE (n = 28) | Non-ETE (n = 79) |
| ETE (n = 12) | Non-ETE (n = 34) |
| ETE (n = 13) | Non-ETE (n = 33) |
| ||
| Sex (M/F) | 5/23 | 27/52 | 0.105 | 1/11 | 6/28 | 0.440 | 2/11 | 11/22 | 0.223 | |
| Age (Years)a | 44.82 ± 12.41 | 47.14 ± 12.07 | 0.388 | 53.42 ± 13.06 | 48.88 ± 13.36 | 0.315 | 40.77 ± 14.66 | 39.39 ± 12.17 | 0.764 | |
| Diameter (mm)a | 1.53 ± 0.81 | 1.41 ± 1.29 | 0.627 | 1.28 ± 0.65 | 1.86 ± 1.35 | 0.059 | 1.77 ± 0.61 | 1.78 ± 1.12 | 0.962 | |
| Hormone (mIU/L)a | TSH | 2.53 ± 1.03 | 2.14 ± 1.31 | 0.480 | 4.43 ± 7.71 | 2.20 ± 1.57 | 0.362 | 123.92 ± 181.05 | 54.44 ± 84.77 | 0.30 |
| FT4 | 15.91 ± 3.02 | 16.01 ± 2.27 | 0.861 | 15.50 ± 1.90 | 16.24 ± 2.60 | 0.390 | 2.77 ± 1.94 | 2.26 ± 1.36 | 0.328 | |
| FT3 | 4.84 ± 0.84 | 4.82 ± 0.61 | 0.936 | 5.08 ± 1.47 | 4.85 ± 0.74 | 0.504 | 11.95 ± 2.08 | 13.85 ± 2.06 | 0.01* | |
| T Stage | T1 | 6 (21.43) | 61 (53.16) | <0.001* | 4 (33.33) | 22 (64.71) | 0.014* | 3 (23.08) | 26 (78.78) | <0.001* |
| T2 | 1 (3.57) | 14 (1.27) | 1 (8.33) | 9 (26.47) | 0(0.00) | 5 (15.15) | ||||
| T3 | 15 (53.57) | 4 (45.57) | 5 (41.67) | 3 (8.82) | 5 (38.46) | 2 (6.06) | ||||
| T4 | 6 (21.43) | 0 (0.00) | 2 (16.67) | 0 (0.00) | 5 (38.46) | 0 (0.00) | ||||
| Primary site | Left/right lobe | 28 (100.00) | 77 (97.47) | 0.395 | 12 (100.00) | 33 (97.06) | 0.548 | 13 (100.00) | 32 (96.97) | >0.999 |
| Isthmus | 0 (0.00) | 2 (2.53) | 0 (0.00) | 1 (2.94) | 0 (0.00) | 1 (3.03) | ||||
| Radiologists’ Interpretation | correct | 21 (75.00) | 64 (81.01) | 0.449 | 7 (58.33) | 29 (85.29) | 0.052 | 10 (76.92) | 23 (69.70) | 0.729 |
| incorrect | 7 (25.00) | 15 (18.99) | 5 (41.67) | 5 (14.71) | 3 (23.08) | 10 (30.30) | ||||
| LN Status | positive | 19 (67.86) | 32 (40.51) | 0.013* | 8(66.67) | 10 (29.41) | 0.157 | 10 (76.92) | 18 (54.55) | 0.197 |
| negative | 9 (32.14) | 47 (59.49) | 4 (33.33) | 24 (70.59) | 3 (23.08) | 15(45.45) | ||||
The data are displayed as n (%) except otherwise noted.
aMean ± standard deviation.
ETE, Extrathyroidal Extension; M, Male; F, Female; TSH, Thyroid Stimulating Hormone; FT4, Free Thyroxine; FT3, Free Triiodothyronine; LN, lymph node.
*P < 0.05
Figure 2Least absolute shrinkage and selection operator (LASSO) algorithm for radiomics features selection. (A) LASSO coefficient profiles of the 4 features. The y-axis represents coefficient of each feature. (B) Mean square error path.
LASSO coefficient profiles of the 4 features.
| Radiomics features | Phase | Feature type | Coefficient |
|---|---|---|---|
| Small Area Low Gray Level Emphasis | Non-contrast | GLSZM | 0.0426553 |
| Gray Level Variance | Non-contrast | GLSZM | -0.023849 |
| Difference Entropy | Non-contrast | GLSZM | 0.014683 |
| Busyness | Non-contrast | GLSZM | -0.007175 |
LASSO, least absolute shrinkage and selection operator; GLSZM, gray-level size zone matrix.
Figure 3Receiver operating characteristic (ROC) curves of different models in training and test sets. Receiver operating characteristic (ROC) curves of K-Nearest Neighbor (KNN), Logistics Regression (LR), Decision Tree (DT), Linear-support vector machine (Linear-SVM), Gaussian-SVM, and Polynomial-SVM models in the training (A) and internal test (B) set. ROC curves of nomogram, radiomics signature, and radiologists’ interpretation in the training (C), internal test (D), external test (E) set. ROC curves of nomogram for division of minimal and gross extrathyroidal extension (ETE) in the internal test and external test set (F).
The selection of clinical risk factors for ETE by ANOVA and univariate LR analysis.
| Variables | ANOVA | Univariate LR Analysis | ||
|---|---|---|---|---|
| F Value | P | OR | P | |
| Sex | 2.642 | 0.107 | NA | NA |
| Age | 0.752 | 0.388 | NA | NA |
| Primary Site | 0.612 | 0.436 | NA | NA |
| Tumor Diameter | 0.065 | 0.799 | NA | NA |
| Radiologist’s Interpretation | 33.412 | <0.01* | 1.506 | <0.01* |
ETE, extrathyroidal extension; ANOVA, analysis of variance; LR, logistic regression; OR, odds ratio; NA, not available.
*P < 0.05
Figure 4Radiomics nomogram with radiomics signature (rad-score) and radiologists’ interpretation incorporated.
Efficacies of the models predicting ETE in patients with PTC.
| AUC | Sensitivity | Specificity | Accuracy | |
|---|---|---|---|---|
|
| ||||
| Rad-score | 0.774 (0.677-0.871) | 0.722 (0.671-0.861) | 0.750 (0.571-0.893) | 0.757 (0.665-0.835) |
| Radiologists’ interpretation | 0.762 (0.667-0.858) | 0.810 (0.712-0.886) | 0.714 (0.536-0.857) | 0.785 (0.695-0.859) |
| Nomogram | 0.860 (0.790-0.931) | 0.734 (0.633-0.853) | 0.786 (0.643-0.929) | 0.710 (0.615-0.794) |
|
| ||||
| Rad-score | 0.701 (0.545-0.857) | 0.706 (0.588-0.882) | 0.583 (0.333-0.833) | 0.674 (0.520-0.805) |
| Radiologists’ interpretation | 0.718 (0.560-0.876) | 0.853 (0.706-0.971) | 0.583 (0.333-0.833) | 0.783 (0.636-0.891) |
| Nomogram | 0.750 (0.579-0.921) | 0.765 (0.584-0.886) | 0.583 (0.333-0.833) | 0.717 (0.565-0.840) |
|
| ||||
| Rad-score | 0.606 (0.469-0.748) | 0.692 (0.389-0.896) | 0.485 (0.312-0.661) | 0.543 (0.390-0.691) |
| Radiologists’ interpretation | 0.733 (0.615-0.841) | 0.769 (0.460-0.938) | 0.697 (0.511-0.838) | 0.717 (0.565-0.840) |
| Nomogram | 0.797 (0.665-0.926) | 0.692 (0.389-0.896) | 0.909 (0.745-0.976) | 0.848 (0.711-0.937) |
ETE, extrathyroidal extension; PTC, Papillary thyroid cancer; Rad-score, radiomics signature score; AUC, area under curves.
Figure 5(A, B) Decision curve analysis (DCA) for the prediction models in the internal and external test set. The y-axis represents the net benefits, while the x-axis represents the threshold probability. The blue line represents the radiomics nomogram. The red line represents the radiologists’ interpretation model. The gray line represents the assumption that no patients were diagnosed as ETE. The horizontal black line represents the assumption that all patients were diagnosed as ETE. Calibration curves of radiomics nomogram in the training (C), internal test (C), and external test (D) sets. The diagonal line represents the perfect prediction of the radiomics nomogram.